Filling the need for trusted information on national health issues…

Vaccines

  • Your Selections:

Refine Results

date

Tags

GAVI Alliance Releases Mid-Term Review

The GAVI Alliance released its 2013 Mid-Term Review, which reports on the organization’s 2011-2015 strategy. The report, including an overview and sections on results, challenges, prospects and key indicators, is available online (October 2013).

Editorials Address Prospect Of Malaria Vaccine

“The Sixth Pan African Multilateral Initiative on Malaria, the world’s largest conference on malaria, took place in Durban, South Africa, [last] week, where results from the most clinically advanced trials showed that over 18 months of follow-up, the RTS,S vaccine almost halved the number of malaria cases in young children…

Experts Say Rabies Kills 24,000 People Annually In Africa

“Rabies kills 24,000 people a year in Africa, most of them children, because many on the world’s poorest continent cannot afford the cost of the vaccine, experts said on Thursday” at a conference of rabies experts held in Dakar, Reuters reports. “Africa is home to nearly half the 55,000 people…

‘Science Speaks’ Features Several Posts On AIDS Vaccine 2013 Conference

The Center for Global Health Policy’s “Science Speaks” blog features a series of blog posts on issues discussed at the AIDS Vaccine 2013 conference that recently concluded in Barcelona. The blog includes a post discussing the need to include married or cohabitating couples in HIV prevention trials; a post discussing next…

Innovation, Partnership Necessary To Bring Vaccines To The Poor

Noting the WHO this week endorsed a new Chinese-produced Japanese encephalitis vaccine, Bill Gates, co-chair of the Bill & Melinda Gates Foundation writes in the organization’s “Impatient Optimists” blog, “[T]here’s a powerful story here about the tremendous progress the world is making to save and improve the lives of the…

Experts React To GSK’s Planned Filing For Approval Of Malaria Vaccine

“Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday to news that the first vaccine against the killer disease may soon reach the market,” Agence France-Presse reports. “GlaxoSmithKline said it was seeking approval for a prototype vaccine that reduced the risk of malaria…

PBS NewsHour Reports On Pakistan’s Polio Vaccination Campaign Setbacks

PBS NewsHour on Monday aired a video report on setbacks in the polio vaccination campaign in Pakistan, “where there have recently been a series of attacks on those trying to administer vaccines.” Special correspondent Fred de Sam Lazaro reports the country’s polio campaign began to stall “thanks to epic floods,…

Bill And Melinda Gates Discuss Public Health Issues In New York Times Interview

The New York Times features a conversation with Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation. In the interview, they discuss the foundation’s family planning advocacy, support for research to find an AIDS vaccine, and efforts to create what Bill Gates refers to as “a toilet…

GSK To Seek Marketing Approval For Malaria Vaccine From European Medicines Agency

“British drugmaker GlaxoSmithKline [GSK] will seek marketing approval for the world’s first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children,” Reuters reports. “The vaccine known as RTS,S was found, after 18 months of follow-up, to have almost halved the…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.